First Annual Off-Label Therapy Forum
September 24, 2008
The George Washington University
Washington, D.C.
Speaker Presentations:
- Off Label Drugs In Cancer Care: The Dilemmas Of Our Choices
Len Lichtenfeld, MD, MACP, American Cancer Society
- Medicare and the New Direction of Compendia
Louis B. Jacques, MD, Centers for Medicare & Medicaid Services (presentation unavailable)
- Panel—The New Recognized Medicare Compendia: Process and Review
- Clinical Pharmacology
Kathleen Vieson, PharmD, BCOP, Gold Standard, Inc. - AHFS-DI (presentation forthcoming)
Gerry McEvoy, PharmD, American Hospital Formulary Service - NCCN Drugs & Biologics Compendium
Kristina Gregory, RN, MSN, OCN, National Comprehensive Cancer Network - DRUGDEX
Jill Sutton, Thomson Micromedex (presentation forthcoming)
- Clinical Pharmacology
- Off-Label Promotion vs. Off-Label Use: Points of Distinction
Susan G. Winkler, United States Attorney’s Office, District of Massachusetts (presentation forthcoming)
- Off-Label Communications
Dan Miller, Office of the Attorney General, Delaware (presentation unavailable)
- Patient Access to Therapies
Nancy Davenport-Ennis, Patient Advocate Foundation (presentation forthcoming)